Oral vitamin B12 therapy: A cautionary note [3]

Blood

Volumn 103, Issue 7, 2004, Pages 2863-

  Solomon, Lawrence R ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN;

COGNITIVE DEFECT; CYANOCOBALAMIN DEFICIENCY; DRUG EFFICACY; DRUG SOLUBILITY; GASTROINTESTINAL ABSORPTION; HUMAN; ILEUM; LETTER; PERNICIOUS ANEMIA; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TIMED DRUG RELEASE; VITAMIN SUPPLEMENTATION; CHEMISTRY; DELAYED RELEASE FORMULATION; INTESTINE ABSORPTION; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; HUMANS; INTESTINAL ABSORPTION; VITAMIN B 12;

EID: 1642281645     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-12-4363     Document Type: Letter

References (3)

1. Chanarin I. The Megaloblastic Anemias. 2nd ed. Oxford, England: Blackwell Scientific Publications; 1979.
2. Kuzminski AM, Del Giacco EJ, Allen AH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 1998;92:1191-1198.
3. Martin DC, Francis J, Protetch J, Huff FJ. Time dependency of cognitive recovery with cobalamin replacement: a pilot study. J Am Geriatr Soc. 1992;40:168-172.